Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,206 | 489 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,699 | 163 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,156 | 76 | $0 (2024) |
| Janssen Biotech, Inc. | $687.03 | 41 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $637.65 | 48 | $0 (2024) |
| Celgene Corporation | $378.38 | 34 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $315.16 | 12 | $0 (2023) |
| Gilead Sciences, Inc. | $274.22 | 12 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $163.55 | 10 | $0 (2023) |
| Merck Sharp & Dohme LLC | $152.79 | 8 | $0 (2023) |
| GENZYME CORPORATION | $152.41 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,981 | 109 | ABBVIE INC. ($656.65) |
| 2023 | $1,695 | 107 | AbbVie Inc. ($588.07) |
| 2022 | $1,902 | 129 | ABBVIE INC. ($462.41) |
| 2021 | $1,113 | 59 | AbbVie Inc. ($414.49) |
| 2020 | $890.36 | 55 | AbbVie Inc. ($384.78) |
| 2019 | $520.85 | 29 | AbbVie, Inc. ($192.20) |
| 2018 | $103.86 | 1 | Intercept Pharmaceuticals, Inc. ($103.86) |
All Payment Transactions
489 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.48 | General |
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/25/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 452 | 507 | $136,137 | $46,171 |
| 2022 | 10 | 572 | 632 | $184,209 | $62,671 |
| 2021 | 9 | 598 | 674 | $175,786 | $64,627 |
| 2020 | 10 | 449 | 505 | $127,753 | $46,628 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 73 | 77 | $36,883 | $14,160 | 38.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 98 | 112 | $29,792 | $7,856 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 79 | $14,308 | $6,532 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $10,601 | $4,588 | 43.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 40 | $16,120 | $2,812 | 17.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $4,707 | $2,048 | 43.5% |
| 43450 | Dilation of esophagus | Facility | 2023 | 57 | 63 | $8,631 | $1,844 | 21.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $4,690 | $1,684 | 35.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 27 | $2,864 | $1,589 | 55.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $3,041 | $1,545 | 50.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $4,500 | $1,512 | 33.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 125 | 129 | $61,791 | $22,920 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 129 | $22,305 | $11,410 | 51.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 131 | 141 | $37,506 | $8,940 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 65 | 65 | $15,964 | $6,552 | 41.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 15 | 15 | $8,600 | $3,771 | 43.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 45 | $18,135 | $2,564 | 14.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $4,690 | $2,136 | 45.5% |
| 43450 | Dilation of esophagus | Facility | 2022 | 61 | 63 | $8,631 | $1,801 | 20.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $4,275 | $1,367 | 32.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,312 | $1,211 | 52.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 121 | 123 | $58,917 | $23,390 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 141 | $23,265 | $12,220 | 52.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 88 | 88 | $22,000 | $10,078 | 45.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 111 | 115 | $30,778 | $7,164 | 23.3% |
About Dr. Frank Wright, M.D
Dr. Frank Wright, M.D is a Gastroenterology healthcare provider based in Maryville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689638884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Wright, M.D has received a total of $8,206 in payments from pharmaceutical and medical device companies, with $1,981 received in 2024. These payments were reported across 489 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,206).
As a Medicare-enrolled provider, Wright has provided services to 2,071 Medicare beneficiaries, totaling 2,318 services with total Medicare billing of $220,097. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Maryville, TN
- Active Since 04/14/2006
- Last Updated 08/06/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1689638884
Products in Payments
- ENTYVIO (Biological) $663.83
- RINVOQ (Biological) $651.60
- STELARA (Biological) $538.86
- LINZESS (Drug) $469.11
- XIFAXAN (Drug) $461.96
- SKYRIZI (Biological) $421.59
- HUMIRA (Biological) $416.57
- ZEPOSIA (Drug) $362.70
- MAVYRET (Drug) $344.28
- OCALIVA (Drug) $298.66
- ZENPEP (Drug) $280.46
- DUPIXENT (Biological) $221.36
- REMICADE (Biological) $190.32
- CREON (Drug) $178.38
- TRULANCE (Drug) $175.69
- GATTEX (Drug) $146.00
- INJECTAFER (Drug) $145.60
- DIFICID (Drug) $136.02
- Humira (Biological) $109.88
- MOTEGRITY (Drug) $109.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Maryville
Dr. William Lyles, Md, MD
Gastroenterology — Payments: $136,354
Dr. Sirisha Jasti, Md, MD
Gastroenterology — Payments: $8,224
Edmundo Rodriguez-Frias, Md, MD
Gastroenterology — Payments: $7,976
Dr. Jennifer Phemister, M.d, M.D
Gastroenterology — Payments: $5,666
Dr. Isaac Cline, M.d, M.D
Gastroenterology — Payments: $4,763
Dr. Michael Coffey, Md, MD
Gastroenterology — Payments: $3,663